The Influence of Incretin Mimetics on Cardiovascular Risk Factors in Diabetes

The authors discuss the strategy of use of incretin hormones in type 2 diabetes treatment in the context of cardiovascular complications. The results of the phase III study on human GLP-1 (Glucagon-like peptide-1) analogue-liraglutide have been presented under common acronym LEAD (Liraglutide-Effect...

Descripción completa

Detalles Bibliográficos
Autores principales: Kinalska, Ida, Bednarska-Chabowska, Dorota, Adamiec-Mroczek, Joanna, Hak, Łukasz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scholarly Research Network 2012
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3302114/
https://www.ncbi.nlm.nih.gov/pubmed/22462016
http://dx.doi.org/10.5402/2012/625809

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3302114/
https://www.ncbi.nlm.nih.gov/pubmed/22462016
http://dx.doi.org/10.5402/2012/625809

Ejemplares similares